Flow Immunology
Jump To:
| A | |
| 02/20/2024 | Activated T-Cell Panel |
| 02/20/2024 | ALPS Panel |
| 02/20/2024 | Antibodies to Extactable Nuclear Antigens |
| B | |
| 02/20/2024 | B-Cell Phenotype Profile |
| C | |
| 02/20/2024 | CD 19/20 Rituximab Panel |
| 02/20/2024 | CD34 Absolute Count |
| 02/20/2024 | CD4 T-Cell Recent Thymic Emigrants (RTE) |
| 02/20/2024 | CD4/CD8 Panel, Blood |
| 02/20/2024 | Cytokine Inflammation 4 Plex Panel |
| 02/20/2024 | Cytokine Panel 13, Serum |
| 02/20/2024 | Cytokine Storm 4 Plex Panel |
| L | |
| 02/20/2024 | Leukemia/Lymphoma Panel |
| 02/20/2024 | Lymphocyte Enumeration- ALPS Panel |
| M | |
| 02/20/2024 | Minimal Residual Disease (MRD) Flow Cytometry for B-ALL (UM) |
| 02/20/2024 | Minimal Residual Disease (MRD) University of Washington |
| Q | |
| 02/20/2024 | Quantitative Lymphocyte Subsets: T,B,NK |
| R | |
| 02/20/2024 | Reflexive Antinuclear Antibody Profile |
| S | |
| 02/20/2024 | Soluble CD163 (SCD163) |
| T | |
| 02/20/2024 | T-Cell Receptor Excision Circles (TREC) Analysis |